SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense community debate as the stock struggles near key support levels, with investors divided between those viewing the recent pullback as a deep-value opportunity and others expressing concern over debt levels and AI-related capital expenditures. The community is actively tracking institutional accumulation, the stock's role in the AI data center buildout, and its sensitivity to broader software sector sentiment.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is capturing significant attention from retail traders following the announcement of a transformative licensing deal, which has triggered intense volatility and speculation regarding the stock's future valuation. Community discussions are split between bulls highlighting the company's strong institutional backing and growth potential, while bears focus on short-selling activity, liquidity concerns, and potential dilution risks.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is seeing significant activity following the appointment of former Disney executive Alisa Bowen as the new CEO, fueling investor optimism for a potential operational turnaround and strategic shift. While the community remains divided over the company's past leadership and recent stock performance, many are closely watching for signs of improved integration with Disney's ecosystem and potential future profitability.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is currently in the spotlight as investors weigh concerns over growth acceleration and e-commerce pixel adoption against strong institutional backing and enthusiasm for its AI-driven advertising technology. While some community members remain skeptical of its price action and volatility, active traders are closely monitoring key support levels and price action as they look for signs of a sustained breakout.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as shareholders weigh the long-term impact of newly approved share authorizations, which management aims to utilize for a potential strategic acquisition of eBay. Community sentiment remains deeply divided, with some investors accumulating shares in anticipation of a transformative merger, while others express frustration over stagnant price action and the potential for future dilution.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is trending as investors weigh strong script growth and a clear path to profitability against significant short interest and recent capital raises. The community is actively discussing the potential for a short squeeze and long-term acquisition, while monitoring institutional accumulation and upcoming clinical trial milestones.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is currently experiencing significant market volatility and high trading volume as investors react to mixed earnings guidance that prioritizes rapid clinical test volume expansion over immediate revenue growth. While the community remains divided between long-term confidence in the company's MRD diagnostic technology and frustration over the slow pace of reimbursement-driven monetization, many are closely watching for updates on IO coverage and clinical partnerships.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as investors rotate into enterprise software, viewing the company as a key beneficiary of agentic AI integration and critical workflow automation. The stock is seeing significant community attention ahead of upcoming earnings, with active discussions focusing on institutional accumulation, bullish contract news, and its role as a core infrastructure provider for AI-driven enterprise operations.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

Royal Caribbean is currently experiencing significant volatility as investors weigh robust demand and strong booking momentum against broader concerns regarding fuel costs and geopolitical uncertainty. The community is actively debating the stock's resilience, with many bulls focusing on its aggressive growth pipeline and dividend strength while others remain cautious about the impact of macro headwinds on its premium pricing power.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is trending as investors weigh its status as a highly undervalued pure-play AI security stock against upcoming earnings, with significant community debate focused on its potential as a strategic acquisition target compared to higher-valued peers. Market participants are closely watching the stock's performance metrics and institutional interest as a potential precursor to a broader valuation re-rating or a takeover bid.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulmonx Corporation (NASDAQ:LUNG) Receives Consensus Recommendation of "Hold" from Analysts

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) has received an average rating of "Hold" from the eight research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold reco...

Pulmonx (NASDAQ:LUNG) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered Pulmonx from a "hold" rating to a "sell" rating in a research report on Saturday...

Pulmonx's (LUNG) Buy Rating Reiterated at D. Boral Capital

D. Boral Capital reiterated a "buy" rating and issued a $14.00 price target on shares of Pulmonx in a report on Thursday...

Pulmonx Q1 Earnings Call Highlights

Pulmonx (NASDAQ:LUNG) reported first-quarter 2026 worldwide revenue of $20.6 million, as management emphasized early progress on commercial execution, continued advancement of its AeriSeal clinical program, and actions to reduce spending and extend its cash runway. Executives reiterated full-year 20...

Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates

Pulmonx (LUNG) delivered earnings and revenue surprises of 0.00% and +2.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Pulmonx (NASDAQ:LUNG) Releases Quarterly Earnings Results, Meets Expectations

Pulmonx (NASDAQ:LUNG - Get Free Report) released its earnings results on Wednesday. The company reported ($0.33) EPS for the quarter, hitting analysts' consensus estimates of ($0.33). Pulmonx had a...

Pulmonx (LUNG) Projected to Post Earnings on Wednesday

Pulmonx (NASDAQ:LUNG) will be releasing its Q1 2026 earnings after the market closes on Wednesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-29-pulmonx-co-stock...

Pulmonx Corporation (NASDAQ:LUNG) Short Interest Update

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) saw a significant drop in short interest in the month of March. As of March 31st, there was short interest totaling 2,857,097 shares, a drop of...

Hims & Hers Health (HIMS) Soars 11.1%: Is Further Upside Left in the Stock?

Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Pulmonx (NASDAQ:LUNG) Stock Price Up 2.3%  - Still a Buy?

Pulmonx (NASDAQ:LUNG) Shares Up 2.3% - Time to Buy...

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Pulmonx Corp

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

LUNGPulmonx Corp

Fundamentals

Latest LUNG News